Events

Recall of ONLINE DAT BENZODIAZEPINES II FOR COBAS INTEGRA ANALYZERS

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ROCHE DIAGNOSTICS GMBH.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    137607
  • Event Risk Class
    III
  • Event Initiated Date
    2012-02-21
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Reagent mixing information described in the method sheet that was not provided in the tas/tasu of the cobas integra 400/800 for benzodiazepines ii may have an impact on calibration stability.

Device

ONLINE DAT BENZODIAZEPINES II FOR COBAS INTEGRA ANALYZERS
  • Model / Serial
    Model Catalog: 04780248190 (Lot serial: All lots)
  • Product Description
    Online DAT Benzodiazepines II for COBAS INTEGRA ANALYZERS
  • Manufacturer
    ROCHE DIAGNOSTICS GMBH

Manufacturer

ROCHE DIAGNOSTICS GMBH
  • Manufacturer Address
    MANNHEIM
  • Manufacturer Parent Company (2017)
    Roche Holding AG
  • Source
    HC